Angiotensin II type 1 receptor blockers as a first choice in patients with acute myocardial infarction

BACKGROUND/AIMS: Angiotensin II type 1 receptor blockers (ARBs) have not been adequately evaluated in patients without left ventricular (LV) dysfunction or heart failure after acute myocardial infarction (AMI). METHODS: Between November 2005 and January 2008, 6,781 patients who were not receiving an...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Korean J Intern Med
Egile Nagusiak: Lee, Jang Hoon, Bae, Myung Hwan, Yang, Dong Heon, Park, Hun Sik, Cho, Yongkeun, Lee, Won Kee, Jeong, Myung Ho, Kim, Young Jo, Cho, Myeong Chan, Kim, Chong Jin, Chae, Shung Chull
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Association of Internal Medicine 2016
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4773713/
https://ncbi.nlm.nih.gov/pubmed/26701233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2014.268
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak